エルシニア診断の世界市場

エルシニア診断の世界市場は2030年までに3億8,370万米ドルに達する見込み

2024年に2億9,600万米ドルと推定されるエルシニア診断の世界市場は、2030年には3億8,370万米ドルに達し、分析期間2024-2030年のCAGRは4.4%で成長すると予測されます。本レポートで分析したセグメントの1つであるエルシニア診断機器は、CAGR 3.7％を記録し、分析期間終了までに2億5,780万米ドルに達すると予測されます。エルシニア診断キット＆試薬セグメントの成長率は、分析期間中CAGR 6.1％と推定されます。

米国市場は推定8,060万米ドル、中国はCAGR6.9%で成長予測

米国のエルシニア診断市場は2024年に8,060万米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに7,430万米ドルの市場規模に達すると予測され、分析期間2024-2030年のCAGRは6.9%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ2.1%と4.4%と予測されています。欧州では、ドイツがCAGR 2.8%で成長すると予測されています。

世界のエルシニア診断市場- 主要動向と促進要因のまとめ

食中毒に対する意識の高まりがエルシニア診断の需要を後押し？

世界のエルシニア診断市場は、公衆衛生当局、臨床医、食品安全規制当局が、汚染された食品や水から発生する細菌感染と闘う努力を強化するにつれて、着実に拡大しています。エルシニア、特にエルシニア・エンテロコリチカとエルシニア・シュードツベルクローシスは、特に小児や免疫不全者において、胃腸疾患の重大な原因として認識されつつあります。この細菌は、加熱が不十分な豚肉、低温殺菌されていない牛乳、未処理の水と関連していることが多く、サーベイランスの改善と早期発見の重要なターゲットとなっています。食中毒が世界のヘルスケアコストの上昇と生産性の低下に寄与していることから、エルシニア感染の早期かつ正確な診断は公衆衛生の優先事項となっています。人獣共通感染症やアウトブレイクの可能性に関する意識の高まりも、病院、検査機関、食品検査機関に、より強力な診断ツールへの投資を促しています。国の保健システムが疾病追跡能力を強化するにつれて、消化器感染症の診断パネルにエルシニアを含めることが一般的になりつつあります。ルーチン診断は臨床検査室だけでなく、国境検査所、動物病院、食品加工施設でも重視されています。このような努力は、エルシニア関連疾患をより効果的に予防・管理するというコミットメントの高まりを反映しており、診断学は現代の感染症対策戦略における最前線の防御手段として位置づけられています。

分子検査および免疫測定検査における技術の進歩は、検出能力をどのように向上させているのか？

最近の診断技術の進歩は、エルシニア検出法のスピード、感度、特異性を著しく向上させています。伝統的な培養ベースの技術は、現在でも広く使用されているが、より迅速で正確な結果を提供する分子診断法や免疫測定法によって補完されるようになってきています。リアルタイムPCRやマルチプレックスPCRを含むポリメラーゼ連鎖反応（PCR）技術では、臨床サンプルや環境サンプルから直接、多くの場合数時間以内にエルシニアDNAを検出することができます。これらの検査は、長時間の培養の必要性を減らし、臨床医がより早く的を絞った治療を開始するのに役立ちます。酵素結合免疫吸着アッセイ（ELISA）やラテラルフローアッセイもまた、エルシニア菌に特異的な抗原や抗体を同定するために開発されており、ポイントオブケア診断や大規模なスクリーニングプログラムの両方に有用です。バイオセンサー技術、マイクロ流体デバイス、ラボオンチップ・プラットフォームの革新は、資源が限られた環境でも導入可能な、持ち運び可能でユーザーフレンドリーな診断ツールに貢献しています。自動化されたプラットフォームは、集中化された検査室でのスループットをさらに向上させ、人的ミスを減らし、標準化を改善しています。診断企業が複数の病原体を同時に検出できるマルチプレックス・システムに注力するにつれ、エルシニア菌は包括的な消化管パネルに含まれることが多くなり、その可視性と診断収率が向上しています。こうした技術革新は、検査の選択肢を広げるだけでなく、より広範なサーベイランスやアウトブレイクへの迅速な公衆衛生対応をも促進しています。

食品安全規制とサーベイランス慣行の変化は市場力学に影響を与えているか？

食品安全規制と公衆衛生サーベイランスの世界のシフトは、正確でタイムリーなエルシニア診断の需要を促進する上で重要な役割を果たしています。食品の国際取引が拡大するにつれ、細菌性病原体が国境を越えて伝播する可能性も高まり、各国はより厳格な輸出入検査要件を実施するようになっています。欧州食品安全機関（EFSA）、米国食品医薬品局（FDA）、世界保健機関（WHO）などの規制機関は、日常の食品安全監査の一環としてエルシニア菌の検出を含む強固な微生物学的モニタリングシステムの重要性を強調しています。食品加工業界はハザード分析と重要管理点（HACCP）プロトコルを採用しつつあり、コンプライアンスを検証し消費者保護を確保するために信頼性の高い診断法が必要とされています。全国的な疾病サーベイランス・システムは、アウトブレイクをリアルタイムで検出して報告するために強化されており、エルシニアは報告義務のある疾病としてリストアップされるようになってきています。農場から食卓までのトレーサビリティの要求は、農業、動物衛生、食品生産部門に診断の機会を生み出しています。さらに、水源、家畜環境、食品生産ラインにおける細菌汚染物質の特定を目的とした環境モニタリングの取り組みにより、エルシニア診断の応用範囲は病院以外にも広がっています。このような規制上の圧力やモニタリング・イニシアチブは、診断ツールやインフラへの持続的な投資のための強力な基盤を構築し、細菌感染に対する公衆衛生の対応が予防的かつ効果的であり続けることを保証しています。

エルシニア診断市場の長期的成長を支えるコア促進要因とは？

エルシニア診断市場の成長は、ヘルスケア意識、技術革新、公共安全の優先事項、世界ヘルスイニシアチブに関連する複数の収束要因によってもたらされます。主な促進要因は、特に人口密集地や低資源地域における、汚染された食品や水に関連した胃腸感染症の発生率の増加です。食中毒に対する消費者の意識の高まりは、早期のヘルスケアへの取り組みを促し、その結果、利用しやすく正確な診断薬に対する需要を押し上げています。医療提供者が症状の根本原因を迅速に特定し、不必要な抗生物質の使用を最小限に抑えようとするため、臨床現場ではより包括的な診断パネルが求められていることも重要な要因です。人工知能とデータ解析の統合を含む診断プラットフォームの進歩も、より迅速な解釈と診断精度の向上を可能にしています。研究機関、公衆衛生機関、バイオテクノロジー企業間の戦略的パートナーシップは、新規アッセイの開発を加速し、市場開拓を拡大しています。さらに、パンデミックへの備えと抗菌薬耐性（AMR）サーベイランスを強化する世界の取り組みにより、より広範な感染症モニタリング戦略の一環として、エルシニアを含む病原体検出システムへの投資が奨励されています。教育キャンペーンやトレーニングプログラムにより、検査技師やヘルスケア従事者がエルシニア感染を効果的に認識し、検査する能力が向上しています。これらの要因が相まって、市場情勢は強固で拡張可能なものとなっており、技術革新、政策との整合性、公衆衛生の優先事項が相まって、継続的な成長と関連性をもたらしています。

セグメント

製品（エルシニア診断機器、エルシニア診断キットおよび試薬）、診断検査（便培養検査、画像検査、血清学的検査、大腸内視鏡検査、その他の診断検査）、技術（イムノアッセイ技術、DNAプローブ技術、ポリメラーゼ連鎖反応技術、フローサイトメトリー技術、クロマトグラフィー技術、その他の技術）、エンドユーザー（病院エンドユーザー、公衆衛生研究所エンドユーザー、商業研究所エンドユーザー、その他のエンドユーザー）

調査対象企業の例

• Abbott Laboratories
• Abingdon Health
• Affymetrix（now part of Thermo Fisher）
• AID Autoimmun Diagnostika
• BioFire Diagnostics（now part of bioMerieux）
• BioMerieux
• BioPerfectus Technologies
• Bio-Rad Laboratories
• BioThreat Alert（R）（Tetracore）
• Certest Biotec
• Creative Dx（Gentaur distributor）
• Danaher Corporation
• DiaSorin
• DNA-Technology
• EIA/Blot Yersinia kits（TestLine）
• Gold Standard Diagnostics
• Hardy Diagnostics
• Hologic（formerly Gen-Probe）
• Medcaptain Medical Tech
• R-Biopharm AG

AIインテグレーション

Global Industry Analystsは、有効な専門家コンテンツとAIツールによって、市場情報と競合情報を変革しています。

Global Industry Analystsは、LLMや業界固有のSLMを照会する一般的な規範に従う代わりに、ビデオ記録、ブログ、検索エンジン調査、膨大な量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

• 市場概要
• 主要企業
• 市場動向と促進要因
• 世界市場の見通し

第3章 市場分析

• 米国
• カナダ
• 日本
• 中国
• 欧州
• フランス
• ドイツ
• イタリア
• 英国
• スペイン
• ロシア
• その他欧州
• アジア太平洋
• オーストラリア
• インド
• 韓国
• その他アジア太平洋地域
• ラテンアメリカ
• アルゼンチン
• ブラジル
• メキシコ
• その他ラテンアメリカ
• 中東
• イラン
• イスラエル
• サウジアラビア
• アラブ首長国連邦
• その他中東
• アフリカ

第4章 競合

Global Yersinia Diagnostics Market to Reach US$383.7 Million by 2030

The global market for Yersinia Diagnostics estimated at US$296.0 Million in the year 2024, is expected to reach US$383.7 Million by 2030, growing at a CAGR of 4.4% over the analysis period 2024-2030. Yersinia Diagnostic Instruments, one of the segments analyzed in the report, is expected to record a 3.7% CAGR and reach US$257.8 Million by the end of the analysis period. Growth in the Yersinia Diagnostic Kits & Reagents segment is estimated at 6.1% CAGR over the analysis period.

The U.S. Market is Estimated at US$80.6 Million While China is Forecast to Grow at 6.9% CAGR

The Yersinia Diagnostics market in the U.S. is estimated at US$80.6 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$74.3 Million by the year 2030 trailing a CAGR of 6.9% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.1% and 4.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.8% CAGR.

Global Yersinia Diagnostics Market - Key Trends & Drivers Summarized

Is Growing Awareness of Foodborne Diseases Fueling the Demand for Yersinia Diagnostics?

The global Yersinia diagnostics market is expanding steadily as public health authorities, clinicians, and food safety regulators intensify their efforts to combat bacterial infections that arise from contaminated food and water. Yersinia, particularly Yersinia enterocolitica and Yersinia pseudotuberculosis, is increasingly recognized as a significant cause of gastrointestinal illness, particularly in children and immunocompromised individuals. The bacterium is often associated with undercooked pork, unpasteurized milk, and untreated water, making it a key target for improved surveillance and early detection. With foodborne diseases contributing to rising healthcare costs and productivity losses globally, early and accurate diagnosis of Yersinia infections is becoming a public health priority. Increased awareness about zoonotic transmission and potential outbreaks is also prompting hospitals, laboratories, and food testing agencies to invest in more robust diagnostic tools. As national health systems strengthen their disease tracking capabilities, the inclusion of Yersinia in diagnostic panels for gastrointestinal infections is becoming more commonplace. Routine diagnostics are being emphasized not only in clinical laboratories but also in border inspection posts, veterinary centers, and food processing facilities. These efforts reflect a growing commitment to preventing and managing Yersinia-related illnesses more effectively, positioning diagnostics as a frontline defense in modern infectious disease control strategies.

How Are Technological Advances in Molecular and Immunoassay Testing Enhancing Detection Capabilities?

Recent advances in diagnostic technology are significantly improving the speed, sensitivity, and specificity of Yersinia detection methods. Traditional culture-based techniques, while still widely used, are increasingly being supplemented by molecular diagnostics and immunoassays that offer quicker and more precise results. Polymerase chain reaction (PCR) techniques, including real-time and multiplex PCR, allow for the detection of Yersinia DNA directly from clinical or environmental samples, often within a matter of hours. These tests reduce the need for extended incubation periods and help clinicians initiate targeted treatments much sooner. Enzyme-linked immunosorbent assays (ELISAs) and lateral flow assays are also being developed to identify Yersinia-specific antigens or antibodies, making them valuable for both point-of-care diagnostics and large-scale screening programs. Innovations in biosensor technology, microfluidic devices, and lab-on-a-chip platforms are contributing to portable and user-friendly diagnostic tools that can be deployed in resource-limited settings. Automated platforms are further enhancing throughput in centralized laboratories, reducing human error and improving standardization. As diagnostic companies focus on multiplex systems that can simultaneously detect multiple pathogens, Yersinia is increasingly included in comprehensive gastrointestinal panels, increasing its visibility and diagnostic yield. These technological innovations are not only expanding the range of testing options available but are also facilitating broader surveillance and quicker public health responses to outbreaks.

Are Shifts in Food Safety Regulations and Surveillance Practices Impacting Market Dynamics?

Global shifts in food safety regulations and public health surveillance are playing a critical role in driving demand for accurate and timely Yersinia diagnostics. As international trade in food products expands, so does the potential for cross-border transmission of bacterial pathogens, prompting countries to implement stricter import and export testing requirements. Regulatory agencies such as the European Food Safety Authority (EFSA), the U.S. Food and Drug Administration (FDA), and the World Health Organization (WHO) are emphasizing the importance of robust microbiological monitoring systems that include Yersinia detection as part of routine food safety audits. Food processing industries are adopting hazard analysis and critical control point (HACCP) protocols that require reliable diagnostic methods to verify compliance and ensure consumer protection. National disease surveillance systems are being strengthened to detect and report outbreaks in real time, with Yersinia increasingly listed as a reportable disease. The demand for traceability from farm to fork is creating opportunities for diagnostics in agriculture, animal health, and food production sectors. Additionally, environmental monitoring initiatives aimed at identifying bacterial contaminants in water sources, livestock environments, and food production lines are expanding the application of Yersinia diagnostics beyond hospitals. These regulatory pressures and monitoring initiatives are creating a strong foundation for sustained investment in diagnostic tools and infrastructure, ensuring that public health responses to bacterial infections remain proactive and effective.

What Core Drivers Are Supporting Long-Term Growth in the Yersinia Diagnostics Market?

The growth in the Yersinia diagnostics market is driven by multiple converging factors related to healthcare awareness, technological innovation, public safety priorities, and global health initiatives. A primary driver is the increasing incidence of gastrointestinal infections linked to contaminated food and water, particularly in densely populated and low-resource regions. Rising consumer awareness around foodborne illnesses is prompting earlier healthcare engagement, which in turn boosts demand for accessible and accurate diagnostics. Another important factor is the push for more comprehensive diagnostic panels in clinical settings, as healthcare providers seek to identify the root cause of symptoms quickly and minimize unnecessary use of antibiotics. Advances in diagnostic platforms, including the integration of artificial intelligence and data analytics, are also enabling faster interpretation and improved diagnostic accuracy. Strategic partnerships between research institutions, public health agencies, and biotechnology firms are accelerating the development of novel assays and expanding market access. Furthermore, global efforts to strengthen pandemic preparedness and antimicrobial resistance (AMR) surveillance are encouraging investments in pathogen detection systems that include Yersinia as part of a broader infectious disease monitoring strategy. Educational campaigns and training programs are increasing the capacity of laboratory technicians and healthcare workers to recognize and test for Yersinia infections effectively. Together, these factors are establishing a robust and scalable market landscape for Yersinia diagnostics, where innovation, policy alignment, and public health priorities collectively drive continued growth and relevance.

SCOPE OF STUDY:

The report analyzes the Yersinia Diagnostics market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Yersinia Diagnostic Instruments, Yersinia Diagnostic Kits & Reagents); Diagnostic Test (Stool Culture Test, Imaging Tests, Serological Tests, Colonoscopy Test, Other Diagnostic Tests); Technology (Immunoassay Technology, DNA Probes Technology, Polymerase Chain Reaction Technology, Flow Cytometry Technology, Chromatography Technology, Other Technologies); End-Use (Hospitals End-Use, Public Health Laboratories End-Use, Commercial Laboratories End-Use, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 36 Featured) -

• Abbott Laboratories
• Abingdon Health
• Affymetrix (now part of Thermo Fisher)
• AID Autoimmun Diagnostika
• BioFire Diagnostics (now part of bioMerieux)
• BioMerieux
• BioPerfectus Technologies
• Bio-Rad Laboratories
• BioThreat Alert(R) (Tetracore)
• Certest Biotec
• Creative Dx (Gentaur distributor)
• Danaher Corporation
• DiaSorin
• DNA-Technology
• EIA/Blot Yersinia kits (TestLine)
• Gold Standard Diagnostics
• Hardy Diagnostics
• Hologic (formerly Gen-Probe)
• Medcaptain Medical Tech
• R-Biopharm AG

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Tariff Impact on Global Supply Chain Patterns
  • Yersinia Diagnostics - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Rising Incidence of Foodborne Illnesses Propels Demand for Rapid Yersinia Diagnostic Solutions
  • Global Surveillance Programs for Zoonotic Diseases Strengthen the Business Case for Yersinia Testing
  • Increased Emphasis on Food Safety and Hygiene Standards Expands the Addressable Market for Yersinia Detection
  • Advancements in PCR and Molecular Diagnostics Drive Adoption of High-Sensitivity Detection Platforms
  • Biothreat Preparedness and Biosecurity Measures Throw the Spotlight on Yersinia pestis Surveillance
  • Growing Awareness Among Clinicians Accelerates Early Diagnosis and Appropriate Treatment of Yersiniosis
  • Integration of Point-of-Care Technologies Spurs Demand in Remote and Resource-Limited Settings
  • Outbreak Management Protocols Create Opportunities for Real-Time, Multiplex Diagnostic Systems
  • Expansion of Veterinary Diagnostics Strengthens Demand for Yersinia Testing in Animal Reservoirs
  • Evolving Genomic Sequencing Capabilities Drive Innovation in Strain Differentiation and Epidemiological Tracking
  • Decentralization of Diagnostic Services Propels Adoption of Compact and Automated Testing Devices
  • Growing Global Burden of Gastrointestinal Infections Reinforces the Need for Scalable Yersinia Diagnostic Platforms
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Yersinia Diagnostics Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Yersinia Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Yersinia Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 4: World 16-Year Perspective for Yersinia Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Yersinia Diagnostic Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Yersinia Diagnostic Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 7: World 16-Year Perspective for Yersinia Diagnostic Instruments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Yersinia Diagnostic Kits & Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Yersinia Diagnostic Kits & Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 10: World 16-Year Perspective for Yersinia Diagnostic Kits & Reagents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Polymerase Chain Reaction Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Polymerase Chain Reaction Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 13: World 16-Year Perspective for Polymerase Chain Reaction Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Flow Cytometry Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Flow Cytometry Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 16: World 16-Year Perspective for Flow Cytometry Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Chromatography Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Chromatography Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 19: World 16-Year Perspective for Chromatography Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 22: World 16-Year Perspective for Other Technologies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Immunoassay Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Immunoassay Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 25: World 16-Year Perspective for Immunoassay Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for DNA Probes Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 27: World Historic Review for DNA Probes Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 28: World 16-Year Perspective for DNA Probes Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 29: World Recent Past, Current & Future Analysis for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 30: World Historic Review for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 31: World 16-Year Perspective for Hospitals End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 32: World Recent Past, Current & Future Analysis for Public Health Laboratories End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 33: World Historic Review for Public Health Laboratories End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 34: World 16-Year Perspective for Public Health Laboratories End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 35: World Recent Past, Current & Future Analysis for Commercial Laboratories End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 36: World Historic Review for Commercial Laboratories End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 37: World 16-Year Perspective for Commercial Laboratories End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 38: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 39: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 40: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 41: World Recent Past, Current & Future Analysis for Stool Culture Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 42: World Historic Review for Stool Culture Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 43: World 16-Year Perspective for Stool Culture Test by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 44: World Recent Past, Current & Future Analysis for Imaging Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 45: World Historic Review for Imaging Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 46: World 16-Year Perspective for Imaging Tests by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 47: World Recent Past, Current & Future Analysis for Serological Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 48: World Historic Review for Serological Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 49: World 16-Year Perspective for Serological Tests by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 50: World Recent Past, Current & Future Analysis for Colonoscopy Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 51: World Historic Review for Colonoscopy Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 52: World 16-Year Perspective for Colonoscopy Test by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 53: World Recent Past, Current & Future Analysis for Other Diagnostic Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 54: World Historic Review for Other Diagnostic Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 55: World 16-Year Perspective for Other Diagnostic Tests by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Yersinia Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 56: USA Recent Past, Current & Future Analysis for Yersinia Diagnostics by Product - Yersinia Diagnostic Instruments and Yersinia Diagnostic Kits & Reagents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 57: USA Historic Review for Yersinia Diagnostics by Product - Yersinia Diagnostic Instruments and Yersinia Diagnostic Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 58: USA 16-Year Perspective for Yersinia Diagnostics by Product - Percentage Breakdown of Value Sales for Yersinia Diagnostic Instruments and Yersinia Diagnostic Kits & Reagents for the Years 2014, 2025 & 2030
  • TABLE 59: USA Recent Past, Current & Future Analysis for Yersinia Diagnostics by Technology - Polymerase Chain Reaction Technology, Flow Cytometry Technology, Chromatography Technology, Other Technologies, Immunoassay Technology and DNA Probes Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 60: USA Historic Review for Yersinia Diagnostics by Technology - Polymerase Chain Reaction Technology, Flow Cytometry Technology, Chromatography Technology, Other Technologies, Immunoassay Technology and DNA Probes Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 61: USA 16-Year Perspective for Yersinia Diagnostics by Technology - Percentage Breakdown of Value Sales for Polymerase Chain Reaction Technology, Flow Cytometry Technology, Chromatography Technology, Other Technologies, Immunoassay Technology and DNA Probes Technology for the Years 2014, 2025 & 2030
  • TABLE 62: USA Recent Past, Current & Future Analysis for Yersinia Diagnostics by End-Use - Hospitals End-Use, Public Health Laboratories End-Use, Commercial Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 63: USA Historic Review for Yersinia Diagnostics by End-Use - Hospitals End-Use, Public Health Laboratories End-Use, Commercial Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 64: USA 16-Year Perspective for Yersinia Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Public Health Laboratories End-Use, Commercial Laboratories End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • TABLE 65: USA Recent Past, Current & Future Analysis for Yersinia Diagnostics by Diagnostic Test - Stool Culture Test, Imaging Tests, Serological Tests, Colonoscopy Test and Other Diagnostic Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 66: USA Historic Review for Yersinia Diagnostics by Diagnostic Test - Stool Culture Test, Imaging Tests, Serological Tests, Colonoscopy Test and Other Diagnostic Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 67: USA 16-Year Perspective for Yersinia Diagnostics by Diagnostic Test - Percentage Breakdown of Value Sales for Stool Culture Test, Imaging Tests, Serological Tests, Colonoscopy Test and Other Diagnostic Tests for the Years 2014, 2025 & 2030
• CANADA
  • TABLE 68: Canada Recent Past, Current & Future Analysis for Yersinia Diagnostics by Product - Yersinia Diagnostic Instruments and Yersinia Diagnostic Kits & Reagents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 69: Canada Historic Review for Yersinia Diagnostics by Product - Yersinia Diagnostic Instruments and Yersinia Diagnostic Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 70: Canada 16-Year Perspective for Yersinia Diagnostics by Product - Percentage Breakdown of Value Sales for Yersinia Diagnostic Instruments and Yersinia Diagnostic Kits & Reagents for the Years 2014, 2025 & 2030
  • TABLE 71: Canada Recent Past, Current & Future Analysis for Yersinia Diagnostics by Technology - Polymerase Chain Reaction Technology, Flow Cytometry Technology, Chromatography Technology, Other Technologies, Immunoassay Technology and DNA Probes Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 72: Canada Historic Review for Yersinia Diagnostics by Technology - Polymerase Chain Reaction Technology, Flow Cytometry Technology, Chromatography Technology, Other Technologies, Immunoassay Technology and DNA Probes Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 73: Canada 16-Year Perspective for Yersinia Diagnostics by Technology - Percentage Breakdown of Value Sales for Polymerase Chain Reaction Technology, Flow Cytometry Technology, Chromatography Technology, Other Technologies, Immunoassay Technology and DNA Probes Technology for the Years 2014, 2025 & 2030
  • TABLE 74: Canada Recent Past, Current & Future Analysis for Yersinia Diagnostics by End-Use - Hospitals End-Use, Public Health Laboratories End-Use, Commercial Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 75: Canada Historic Review for Yersinia Diagnostics by End-Use - Hospitals End-Use, Public Health Laboratories End-Use, Commercial Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 76: Canada 16-Year Perspective for Yersinia Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Public Health Laboratories End-Use, Commercial Laboratories End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • TABLE 77: Canada Recent Past, Current & Future Analysis for Yersinia Diagnostics by Diagnostic Test - Stool Culture Test, Imaging Tests, Serological Tests, Colonoscopy Test and Other Diagnostic Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 78: Canada Historic Review for Yersinia Diagnostics by Diagnostic Test - Stool Culture Test, Imaging Tests, Serological Tests, Colonoscopy Test and Other Diagnostic Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 79: Canada 16-Year Perspective for Yersinia Diagnostics by Diagnostic Test - Percentage Breakdown of Value Sales for Stool Culture Test, Imaging Tests, Serological Tests, Colonoscopy Test and Other Diagnostic Tests for the Years 2014, 2025 & 2030
• JAPAN
  • Yersinia Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 80: Japan Recent Past, Current & Future Analysis for Yersinia Diagnostics by Product - Yersinia Diagnostic Instruments and Yersinia Diagnostic Kits & Reagents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 81: Japan Historic Review for Yersinia Diagnostics by Product - Yersinia Diagnostic Instruments and Yersinia Diagnostic Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 82: Japan 16-Year Perspective for Yersinia Diagnostics by Product - Percentage Breakdown of Value Sales for Yersinia Diagnostic Instruments and Yersinia Diagnostic Kits & Reagents for the Years 2014, 2025 & 2030
  • TABLE 83: Japan Recent Past, Current & Future Analysis for Yersinia Diagnostics by Technology - Polymerase Chain Reaction Technology, Flow Cytometry Technology, Chromatography Technology, Other Technologies, Immunoassay Technology and DNA Probes Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 84: Japan Historic Review for Yersinia Diagnostics by Technology - Polymerase Chain Reaction Technology, Flow Cytometry Technology, Chromatography Technology, Other Technologies, Immunoassay Technology and DNA Probes Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 85: Japan 16-Year Perspective for Yersinia Diagnostics by Technology - Percentage Breakdown of Value Sales for Polymerase Chain Reaction Technology, Flow Cytometry Technology, Chromatography Technology, Other Technologies, Immunoassay Technology and DNA Probes Technology for the Years 2014, 2025 & 2030
  • TABLE 86: Japan Recent Past, Current & Future Analysis for Yersinia Diagnostics by End-Use - Hospitals End-Use, Public Health Laboratories End-Use, Commercial Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 87: Japan Historic Review for Yersinia Diagnostics by End-Use - Hospitals End-Use, Public Health Laboratories End-Use, Commercial Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 88: Japan 16-Year Perspective for Yersinia Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Public Health Laboratories End-Use, Commercial Laboratories End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • TABLE 89: Japan Recent Past, Current & Future Analysis for Yersinia Diagnostics by Diagnostic Test - Stool Culture Test, Imaging Tests, Serological Tests, Colonoscopy Test and Other Diagnostic Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 90: Japan Historic Review for Yersinia Diagnostics by Diagnostic Test - Stool Culture Test, Imaging Tests, Serological Tests, Colonoscopy Test and Other Diagnostic Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 91: Japan 16-Year Perspective for Yersinia Diagnostics by Diagnostic Test - Percentage Breakdown of Value Sales for Stool Culture Test, Imaging Tests, Serological Tests, Colonoscopy Test and Other Diagnostic Tests for the Years 2014, 2025 & 2030
• CHINA
  • Yersinia Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 92: China Recent Past, Current & Future Analysis for Yersinia Diagnostics by Product - Yersinia Diagnostic Instruments and Yersinia Diagnostic Kits & Reagents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 93: China Historic Review for Yersinia Diagnostics by Product - Yersinia Diagnostic Instruments and Yersinia Diagnostic Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 94: China 16-Year Perspective for Yersinia Diagnostics by Product - Percentage Breakdown of Value Sales for Yersinia Diagnostic Instruments and Yersinia Diagnostic Kits & Reagents for the Years 2014, 2025 & 2030
  • TABLE 95: China Recent Past, Current & Future Analysis for Yersinia Diagnostics by Technology - Polymerase Chain Reaction Technology, Flow Cytometry Technology, Chromatography Technology, Other Technologies, Immunoassay Technology and DNA Probes Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 96: China Historic Review for Yersinia Diagnostics by Technology - Polymerase Chain Reaction Technology, Flow Cytometry Technology, Chromatography Technology, Other Technologies, Immunoassay Technology and DNA Probes Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 97: China 16-Year Perspective for Yersinia Diagnostics by Technology - Percentage Breakdown of Value Sales for Polymerase Chain Reaction Technology, Flow Cytometry Technology, Chromatography Technology, Other Technologies, Immunoassay Technology and DNA Probes Technology for the Years 2014, 2025 & 2030
  • TABLE 98: China Recent Past, Current & Future Analysis for Yersinia Diagnostics by End-Use - Hospitals End-Use, Public Health Laboratories End-Use, Commercial Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 99: China Historic Review for Yersinia Diagnostics by End-Use - Hospitals End-Use, Public Health Laboratories End-Use, Commercial Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 100: China 16-Year Perspective for Yersinia Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Public Health Laboratories End-Use, Commercial Laboratories End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • TABLE 101: China Recent Past, Current & Future Analysis for Yersinia Diagnostics by Diagnostic Test - Stool Culture Test, Imaging Tests, Serological Tests, Colonoscopy Test and Other Diagnostic Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 102: China Historic Review for Yersinia Diagnostics by Diagnostic Test - Stool Culture Test, Imaging Tests, Serological Tests, Colonoscopy Test and Other Diagnostic Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 103: China 16-Year Perspective for Yersinia Diagnostics by Diagnostic Test - Percentage Breakdown of Value Sales for Stool Culture Test, Imaging Tests, Serological Tests, Colonoscopy Test and Other Diagnostic Tests for the Years 2014, 2025 & 2030
• EUROPE
  • Yersinia Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 104: Europe Recent Past, Current & Future Analysis for Yersinia Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 105: Europe Historic Review for Yersinia Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 106: Europe 16-Year Perspective for Yersinia Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
  • TABLE 107: Europe Recent Past, Current & Future Analysis for Yersinia Diagnostics by Product - Yersinia Diagnostic Instruments and Yersinia Diagnostic Kits & Reagents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 108: Europe Historic Review for Yersinia Diagnostics by Product - Yersinia Diagnostic Instruments and Yersinia Diagnostic Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 109: Europe 16-Year Perspective for Yersinia Diagnostics by Product - Percentage Breakdown of Value Sales for Yersinia Diagnostic Instruments and Yersinia Diagnostic Kits & Reagents for the Years 2014, 2025 & 2030
  • TABLE 110: Europe Recent Past, Current & Future Analysis for Yersinia Diagnostics by Technology - Polymerase Chain Reaction Technology, Flow Cytometry Technology, Chromatography Technology, Other Technologies, Immunoassay Technology and DNA Probes Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 111: Europe Historic Review for Yersinia Diagnostics by Technology - Polymerase Chain Reaction Technology, Flow Cytometry Technology, Chromatography Technology, Other Technologies, Immunoassay Technology and DNA Probes Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 112: Europe 16-Year Perspective for Yersinia Diagnostics by Technology - Percentage Breakdown of Value Sales for Polymerase Chain Reaction Technology, Flow Cytometry Technology, Chromatography Technology, Other Technologies, Immunoassay Technology and DNA Probes Technology for the Years 2014, 2025 & 2030
  • TABLE 113: Europe Recent Past, Current & Future Analysis for Yersinia Diagnostics by End-Use - Hospitals End-Use, Public Health Laboratories End-Use, Commercial Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 114: Europe Historic Review for Yersinia Diagnostics by End-Use - Hospitals End-Use, Public Health Laboratories End-Use, Commercial Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 115: Europe 16-Year Perspective for Yersinia Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Public Health Laboratories End-Use, Commercial Laboratories End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • TABLE 116: Europe Recent Past, Current & Future Analysis for Yersinia Diagnostics by Diagnostic Test - Stool Culture Test, Imaging Tests, Serological Tests, Colonoscopy Test and Other Diagnostic Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 117: Europe Historic Review for Yersinia Diagnostics by Diagnostic Test - Stool Culture Test, Imaging Tests, Serological Tests, Colonoscopy Test and Other Diagnostic Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 118: Europe 16-Year Perspective for Yersinia Diagnostics by Diagnostic Test - Percentage Breakdown of Value Sales for Stool Culture Test, Imaging Tests, Serological Tests, Colonoscopy Test and Other Diagnostic Tests for the Years 2014, 2025 & 2030
• FRANCE
  • Yersinia Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 119: France Recent Past, Current & Future Analysis for Yersinia Diagnostics by Product - Yersinia Diagnostic Instruments and Yersinia Diagnostic Kits & Reagents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 120: France Historic Review for Yersinia Diagnostics by Product - Yersinia Diagnostic Instruments and Yersinia Diagnostic Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 121: France 16-Year Perspective for Yersinia Diagnostics by Product - Percentage Breakdown of Value Sales for Yersinia Diagnostic Instruments and Yersinia Diagnostic Kits & Reagents for the Years 2014, 2025 & 2030
  • TABLE 122: France Recent Past, Current & Future Analysis for Yersinia Diagnostics by Technology - Polymerase Chain Reaction Technology, Flow Cytometry Technology, Chromatography Technology, Other Technologies, Immunoassay Technology and DNA Probes Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 123: France Historic Review for Yersinia Diagnostics by Technology - Polymerase Chain Reaction Technology, Flow Cytometry Technology, Chromatography Technology, Other Technologies, Immunoassay Technology and DNA Probes Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 124: France 16-Year Perspective for Yersinia Diagnostics by Technology - Percentage Breakdown of Value Sales for Polymerase Chain Reaction Technology, Flow Cytometry Technology, Chromatography Technology, Other Technologies, Immunoassay Technology and DNA Probes Technology for the Years 2014, 2025 & 2030
  • TABLE 125: France Recent Past, Current & Future Analysis for Yersinia Diagnostics by End-Use - Hospitals End-Use, Public Health Laboratories End-Use, Commercial Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 126: France Historic Review for Yersinia Diagnostics by End-Use - Hospitals End-Use, Public Health Laboratories End-Use, Commercial Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 127: France 16-Year Perspective for Yersinia Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Public Health Laboratories End-Use, Commercial Laboratories End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • TABLE 128: France Recent Past, Current & Future Analysis for Yersinia Diagnostics by Diagnostic Test - Stool Culture Test, Imaging Tests, Serological Tests, Colonoscopy Test and Other Diagnostic Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 129: France Historic Review for Yersinia Diagnostics by Diagnostic Test - Stool Culture Test, Imaging Tests, Serological Tests, Colonoscopy Test and Other Diagnostic Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 130: France 16-Year Perspective for Yersinia Diagnostics by Diagnostic Test - Percentage Breakdown of Value Sales for Stool Culture Test, Imaging Tests, Serological Tests, Colonoscopy Test and Other Diagnostic Tests for the Years 2014, 2025 & 2030
• GERMANY
  • Yersinia Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 131: Germany Recent Past, Current & Future Analysis for Yersinia Diagnostics by Product - Yersinia Diagnostic Instruments and Yersinia Diagnostic Kits & Reagents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 132: Germany Historic Review for Yersinia Diagnostics by Product - Yersinia Diagnostic Instruments and Yersinia Diagnostic Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 133: Germany 16-Year Perspective for Yersinia Diagnostics by Product - Percentage Breakdown of Value Sales for Yersinia Diagnostic Instruments and Yersinia Diagnostic Kits & Reagents for the Years 2014, 2025 & 2030
  • TABLE 134: Germany Recent Past, Current & Future Analysis for Yersinia Diagnostics by Technology - Polymerase Chain Reaction Technology, Flow Cytometry Technology, Chromatography Technology, Other Technologies, Immunoassay Technology and DNA Probes Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 135: Germany Historic Review for Yersinia Diagnostics by Technology - Polymerase Chain Reaction Technology, Flow Cytometry Technology, Chromatography Technology, Other Technologies, Immunoassay Technology and DNA Probes Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 136: Germany 16-Year Perspective for Yersinia Diagnostics by Technology - Percentage Breakdown of Value Sales for Polymerase Chain Reaction Technology, Flow Cytometry Technology, Chromatography Technology, Other Technologies, Immunoassay Technology and DNA Probes Technology for the Years 2014, 2025 & 2030
  • TABLE 137: Germany Recent Past, Current & Future Analysis for Yersinia Diagnostics by End-Use - Hospitals End-Use, Public Health Laboratories End-Use, Commercial Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 138: Germany Historic Review for Yersinia Diagnostics by End-Use - Hospitals End-Use, Public Health Laboratories End-Use, Commercial Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 139: Germany 16-Year Perspective for Yersinia Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Public Health Laboratories End-Use, Commercial Laboratories End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • TABLE 140: Germany Recent Past, Current & Future Analysis for Yersinia Diagnostics by Diagnostic Test - Stool Culture Test, Imaging Tests, Serological Tests, Colonoscopy Test and Other Diagnostic Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 141: Germany Historic Review for Yersinia Diagnostics by Diagnostic Test - Stool Culture Test, Imaging Tests, Serological Tests, Colonoscopy Test and Other Diagnostic Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 142: Germany 16-Year Perspective for Yersinia Diagnostics by Diagnostic Test - Percentage Breakdown of Value Sales for Stool Culture Test, Imaging Tests, Serological Tests, Colonoscopy Test and Other Diagnostic Tests for the Years 2014, 2025 & 2030
• ITALY
  • TABLE 143: Italy Recent Past, Current & Future Analysis for Yersinia Diagnostics by Product - Yersinia Diagnostic Instruments and Yersinia Diagnostic Kits & Reagents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 144: Italy Historic Review for Yersinia Diagnostics by Product - Yersinia Diagnostic Instruments and Yersinia Diagnostic Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 145: Italy 16-Year Perspective for Yersinia Diagnostics by Product - Percentage Breakdown of Value Sales for Yersinia Diagnostic Instruments and Yersinia Diagnostic Kits & Reagents for the Years 2014, 2025 & 2030
  • TABLE 146: Italy Recent Past, Current & Future Analysis for Yersinia Diagnostics by Technology - Polymerase Chain Reaction Technology, Flow Cytometry Technology, Chromatography Technology, Other Technologies, Immunoassay Technology and DNA Probes Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 147: Italy Historic Review for Yersinia Diagnostics by Technology - Polymerase Chain Reaction Technology, Flow Cytometry Technology, Chromatography Technology, Other Technologies, Immunoassay Technology and DNA Probes Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 148: Italy 16-Year Perspective for Yersinia Diagnostics by Technology - Percentage Breakdown of Value Sales for Polymerase Chain Reaction Technology, Flow Cytometry Technology, Chromatography Technology, Other Technologies, Immunoassay Technology and DNA Probes Technology for the Years 2014, 2025 & 2030
  • TABLE 149: Italy Recent Past, Current & Future Analysis for Yersinia Diagnostics by End-Use - Hospitals End-Use, Public Health Laboratories End-Use, Commercial Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 150: Italy Historic Review for Yersinia Diagnostics by End-Use - Hospitals End-Use, Public Health Laboratories End-Use, Commercial Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 151: Italy 16-Year Perspective for Yersinia Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Public Health Laboratories End-Use, Commercial Laboratories End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • TABLE 152: Italy Recent Past, Current & Future Analysis for Yersinia Diagnostics by Diagnostic Test - Stool Culture Test, Imaging Tests, Serological Tests, Colonoscopy Test and Other Diagnostic Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 153: Italy Historic Review for Yersinia Diagnostics by Diagnostic Test - Stool Culture Test, Imaging Tests, Serological Tests, Colonoscopy Test and Other Diagnostic Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 154: Italy 16-Year Perspective for Yersinia Diagnostics by Diagnostic Test - Percentage Breakdown of Value Sales for Stool Culture Test, Imaging Tests, Serological Tests, Colonoscopy Test and Other Diagnostic Tests for the Years 2014, 2025 & 2030
• UNITED KINGDOM
  • Yersinia Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 155: UK Recent Past, Current & Future Analysis for Yersinia Diagnostics by Product - Yersinia Diagnostic Instruments and Yersinia Diagnostic Kits & Reagents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 156: UK Historic Review for Yersinia Diagnostics by Product - Yersinia Diagnostic Instruments and Yersinia Diagnostic Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 157: UK 16-Year Perspective for Yersinia Diagnostics by Product - Percentage Breakdown of Value Sales for Yersinia Diagnostic Instruments and Yersinia Diagnostic Kits & Reagents for the Years 2014, 2025 & 2030
  • TABLE 158: UK Recent Past, Current & Future Analysis for Yersinia Diagnostics by Technology - Polymerase Chain Reaction Technology, Flow Cytometry Technology, Chromatography Technology, Other Technologies, Immunoassay Technology and DNA Probes Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 159: UK Historic Review for Yersinia Diagnostics by Technology - Polymerase Chain Reaction Technology, Flow Cytometry Technology, Chromatography Technology, Other Technologies, Immunoassay Technology and DNA Probes Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 160: UK 16-Year Perspective for Yersinia Diagnostics by Technology - Percentage Breakdown of Value Sales for Polymerase Chain Reaction Technology, Flow Cytometry Technology, Chromatography Technology, Other Technologies, Immunoassay Technology and DNA Probes Technology for the Years 2014, 2025 & 2030
  • TABLE 161: UK Recent Past, Current & Future Analysis for Yersinia Diagnostics by End-Use - Hospitals End-Use, Public Health Laboratories End-Use, Commercial Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 162: UK Historic Review for Yersinia Diagnostics by End-Use - Hospitals End-Use, Public Health Laboratories End-Use, Commercial Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 163: UK 16-Year Perspective for Yersinia Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Public Health Laboratories End-Use, Commercial Laboratories End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • TABLE 164: UK Recent Past, Current & Future Analysis for Yersinia Diagnostics by Diagnostic Test - Stool Culture Test, Imaging Tests, Serological Tests, Colonoscopy Test and Other Diagnostic Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 165: UK Historic Review for Yersinia Diagnostics by Diagnostic Test - Stool Culture Test, Imaging Tests, Serological Tests, Colonoscopy Test and Other Diagnostic Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 166: UK 16-Year Perspective for Yersinia Diagnostics by Diagnostic Test - Percentage Breakdown of Value Sales for Stool Culture Test, Imaging Tests, Serological Tests, Colonoscopy Test and Other Diagnostic Tests for the Years 2014, 2025 & 2030
• SPAIN
  • TABLE 167: Spain Recent Past, Current & Future Analysis for Yersinia Diagnostics by Product - Yersinia Diagnostic Instruments and Yersinia Diagnostic Kits & Reagents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 168: Spain Historic Review for Yersinia Diagnostics by Product - Yersinia Diagnostic Instruments and Yersinia Diagnostic Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 169: Spain 16-Year Perspective for Yersinia Diagnostics by Product - Percentage Breakdown of Value Sales for Yersinia Diagnostic Instruments and Yersinia Diagnostic Kits & Reagents for the Years 2014, 2025 & 2030
  • TABLE 170: Spain Recent Past, Current & Future Analysis for Yersinia Diagnostics by Technology - Polymerase Chain Reaction Technology, Flow Cytometry Technology, Chromatography Technology, Other Technologies, Immunoassay Technology and DNA Probes Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 171: Spain Historic Review for Yersinia Diagnostics by Technology - Polymerase Chain Reaction Technology, Flow Cytometry Technology, Chromatography Technology, Other Technologies, Immunoassay Technology and DNA Probes Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 172: Spain 16-Year Perspective for Yersinia Diagnostics by Technology - Percentage Breakdown of Value Sales for Polymerase Chain Reaction Technology, Flow Cytometry Technology, Chromatography Technology, Other Technologies, Immunoassay Technology and DNA Probes Technology for the Years 2014, 2025 & 2030
  • TABLE 173: Spain Recent Past, Current & Future Analysis for Yersinia Diagnostics by End-Use - Hospitals End-Use, Public Health Laboratories End-Use, Commercial Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 174: Spain Historic Review for Yersinia Diagnostics by End-Use - Hospitals End-Use, Public Health Laboratories End-Use, Commercial Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 175: Spain 16-Year Perspective for Yersinia Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Public Health Laboratories End-Use, Commercial Laboratories End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • TABLE 176: Spain Recent Past, Current & Future Analysis for Yersinia Diagnostics by Diagnostic Test - Stool Culture Test, Imaging Tests, Serological Tests, Colonoscopy Test and Other Diagnostic Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 177: Spain Historic Review for Yersinia Diagnostics by Diagnostic Test - Stool Culture Test, Imaging Tests, Serological Tests, Colonoscopy Test and Other Diagnostic Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 178: Spain 16-Year Perspective for Yersinia Diagnostics by Diagnostic Test - Percentage Breakdown of Value Sales for Stool Culture Test, Imaging Tests, Serological Tests, Colonoscopy Test and Other Diagnostic Tests for the Years 2014, 2025 & 2030
• RUSSIA
  • TABLE 179: Russia Recent Past, Current & Future Analysis for Yersinia Diagnostics by Product - Yersinia Diagnostic Instruments and Yersinia Diagnostic Kits & Reagents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 180: Russia Historic Review for Yersinia Diagnostics by Product - Yersinia Diagnostic Instruments and Yersinia Diagnostic Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 181: Russia 16-Year Perspective for Yersinia Diagnostics by Product - Percentage Breakdown of Value Sales for Yersinia Diagnostic Instruments and Yersinia Diagnostic Kits & Reagents for the Years 2014, 2025 & 2030
  • TABLE 182: Russia Recent Past, Current & Future Analysis for Yersinia Diagnostics by Technology - Polymerase Chain Reaction Technology, Flow Cytometry Technology, Chromatography Technology, Other Technologies, Immunoassay Technology and DNA Probes Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 183: Russia Historic Review for Yersinia Diagnostics by Technology - Polymerase Chain Reaction Technology, Flow Cytometry Technology, Chromatography Technology, Other Technologies, Immunoassay Technology and DNA Probes Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 184: Russia 16-Year Perspective for Yersinia Diagnostics by Technology - Percentage Breakdown of Value Sales for Polymerase Chain Reaction Technology, Flow Cytometry Technology, Chromatography Technology, Other Technologies, Immunoassay Technology and DNA Probes Technology for the Years 2014, 2025 & 2030
  • TABLE 185: Russia Recent Past, Current & Future Analysis for Yersinia Diagnostics by End-Use - Hospitals End-Use, Public Health Laboratories End-Use, Commercial Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 186: Russia Historic Review for Yersinia Diagnostics by End-Use - Hospitals End-Use, Public Health Laboratories End-Use, Commercial Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 187: Russia 16-Year Perspective for Yersinia Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Public Health Laboratories End-Use, Commercial Laboratories End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • TABLE 188: Russia Recent Past, Current & Future Analysis for Yersinia Diagnostics by Diagnostic Test - Stool Culture Test, Imaging Tests, Serological Tests, Colonoscopy Test and Other Diagnostic Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 189: Russia Historic Review for Yersinia Diagnostics by Diagnostic Test - Stool Culture Test, Imaging Tests, Serological Tests, Colonoscopy Test and Other Diagnostic Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 190: Russia 16-Year Perspective for Yersinia Diagnostics by Diagnostic Test - Percentage Breakdown of Value Sales for Stool Culture Test, Imaging Tests, Serological Tests, Colonoscopy Test and Other Diagnostic Tests for the Years 2014, 2025 & 2030
• REST OF EUROPE
  • TABLE 191: Rest of Europe Recent Past, Current & Future Analysis for Yersinia Diagnostics by Product - Yersinia Diagnostic Instruments and Yersinia Diagnostic Kits & Reagents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 192: Rest of Europe Historic Review for Yersinia Diagnostics by Product - Yersinia Diagnostic Instruments and Yersinia Diagnostic Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 193: Rest of Europe 16-Year Perspective for Yersinia Diagnostics by Product - Percentage Breakdown of Value Sales for Yersinia Diagnostic Instruments and Yersinia Diagnostic Kits & Reagents for the Years 2014, 2025 & 2030
  • TABLE 194: Rest of Europe Recent Past, Current & Future Analysis for Yersinia Diagnostics by Technology - Polymerase Chain Reaction Technology, Flow Cytometry Technology, Chromatography Technology, Other Technologies, Immunoassay Technology and DNA Probes Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 195: Rest of Europe Historic Review for Yersinia Diagnostics by Technology - Polymerase Chain Reaction Technology, Flow Cytometry Technology, Chromatography Technology, Other Technologies, Immunoassay Technology and DNA Probes Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 196: Rest of Europe 16-Year Perspective for Yersinia Diagnostics by Technology - Percentage Breakdown of Value Sales for Polymerase Chain Reaction Technology, Flow Cytometry Technology, Chromatography Technology, Other Technologies, Immunoassay Technology and DNA Probes Technology for the Years 2014, 2025 & 2030
  • TABLE 197: Rest of Europe Recent Past, Current & Future Analysis for Yersinia Diagnostics by End-Use - Hospitals End-Use, Public Health Laboratories End-Use, Commercial Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 198: Rest of Europe Historic Review for Yersinia Diagnostics by End-Use - Hospitals End-Use, Public Health Laboratories End-Use, Commercial Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 199: Rest of Europe 16-Year Perspective for Yersinia Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Public Health Laboratories End-Use, Commercial Laboratories End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • TABLE 200: Rest of Europe Recent Past, Current & Future Analysis for Yersinia Diagnostics by Diagnostic Test - Stool Culture Test, Imaging Tests, Serological Tests, Colonoscopy Test and Other Diagnostic Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 201: Rest of Europe Historic Review for Yersinia Diagnostics by Diagnostic Test - Stool Culture Test, Imaging Tests, Serological Tests, Colonoscopy Test and Other Diagnostic Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 202: Rest of Europe 16-Year Perspective for Yersinia Diagnostics by Diagnostic Test - Percentage Breakdown of Value Sales for Stool Culture Test, Imaging Tests, Serological Tests, Colonoscopy Test and Other Diagnostic Tests for the Years 2014, 2025 & 2030
• ASIA-PACIFIC
  • Yersinia Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 203: Asia-Pacific Recent Past, Current & Future Analysis for Yersinia Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 204: Asia-Pacific Historic Review for Yersinia Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 205: Asia-Pacific 16-Year Perspective for Yersinia Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
  • TABLE 206: Asia-Pacific Recent Past, Current & Future Analysis for Yersinia Diagnostics by Product - Yersinia Diagnostic Instruments and Yersinia Diagnostic Kits & Reagents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 207: Asia-Pacific Historic Review for Yersinia Diagnostics by Product - Yersinia Diagnostic Instruments and Yersinia Diagnostic Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 208: Asia-Pacific 16-Year Perspective for Yersinia Diagnostics by Product - Percentage Breakdown of Value Sales for Yersinia Diagnostic Instruments and Yersinia Diagnostic Kits & Reagents for the Years 2014, 2025 & 2030
  • TABLE 209: Asia-Pacific Recent Past, Current & Future Analysis for Yersinia Diagnostics by Technology - Polymerase Chain Reaction Technology, Flow Cytometry Technology, Chromatography Technology, Other Technologies, Immunoassay Technology and DNA Probes Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 210: Asia-Pacific Historic Review for Yersinia Diagnostics by Technology - Polymerase Chain Reaction Technology, Flow Cytometry Technology, Chromatography Technology, Other Technologies, Immunoassay Technology and DNA Probes Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 211: Asia-Pacific 16-Year Perspective for Yersinia Diagnostics by Technology - Percentage Breakdown of Value Sales for Polymerase Chain Reaction Technology, Flow Cytometry Technology, Chromatography Technology, Other Technologies, Immunoassay Technology and DNA Probes Technology for the Years 2014, 2025 & 2030
  • TABLE 212: Asia-Pacific Recent Past, Current & Future Analysis for Yersinia Diagnostics by End-Use - Hospitals End-Use, Public Health Laboratories End-Use, Commercial Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 213: Asia-Pacific Historic Review for Yersinia Diagnostics by End-Use - Hospitals End-Use, Public Health Laboratories End-Use, Commercial Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 214: Asia-Pacific 16-Year Perspective for Yersinia Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Public Health Laboratories End-Use, Commercial Laboratories End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • TABLE 215: Asia-Pacific Recent Past, Current & Future Analysis for Yersinia Diagnostics by Diagnostic Test - Stool Culture Test, Imaging Tests, Serological Tests, Colonoscopy Test and Other Diagnostic Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 216: Asia-Pacific Historic Review for Yersinia Diagnostics by Diagnostic Test - Stool Culture Test, Imaging Tests, Serological Tests, Colonoscopy Test and Other Diagnostic Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 217: Asia-Pacific 16-Year Perspective for Yersinia Diagnostics by Diagnostic Test - Percentage Breakdown of Value Sales for Stool Culture Test, Imaging Tests, Serological Tests, Colonoscopy Test and Other Diagnostic Tests for the Years 2014, 2025 & 2030
• AUSTRALIA
  • Yersinia Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 218: Australia Recent Past, Current & Future Analysis for Yersinia Diagnostics by Product - Yersinia Diagnostic Instruments and Yersinia Diagnostic Kits & Reagents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 219: Australia Historic Review for Yersinia Diagnostics by Product - Yersinia Diagnostic Instruments and Yersinia Diagnostic Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 220: Australia 16-Year Perspective for Yersinia Diagnostics by Product - Percentage Breakdown of Value Sales for Yersinia Diagnostic Instruments and Yersinia Diagnostic Kits & Reagents for the Years 2014, 2025 & 2030
  • TABLE 221: Australia Recent Past, Current & Future Analysis for Yersinia Diagnostics by Technology - Polymerase Chain Reaction Technology, Flow Cytometry Technology, Chromatography Technology, Other Technologies, Immunoassay Technology and DNA Probes Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 222: Australia Historic Review for Yersinia Diagnostics by Technology - Polymerase Chain Reaction Technology, Flow Cytometry Technology, Chromatography Technology, Other Technologies, Immunoassay Technology and DNA Probes Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 223: Australia 16-Year Perspective for Yersinia Diagnostics by Technology - Percentage Breakdown of Value Sales for Polymerase Chain Reaction Technology, Flow Cytometry Technology, Chromatography Technology, Other Technologies, Immunoassay Technology and DNA Probes Technology for the Years 2014, 2025 & 2030
  • TABLE 224: Australia Recent Past, Current & Future Analysis for Yersinia Diagnostics by End-Use - Hospitals End-Use, Public Health Laboratories End-Use, Commercial Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 225: Australia Historic Review for Yersinia Diagnostics by End-Use - Hospitals End-Use, Public Health Laboratories End-Use, Commercial Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 226: Australia 16-Year Perspective for Yersinia Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Public Health Laboratories End-Use, Commercial Laboratories End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • TABLE 227: Australia Recent Past, Current & Future Analysis for Yersinia Diagnostics by Diagnostic Test - Stool Culture Test, Imaging Tests, Serological Tests, Colonoscopy Test and Other Diagnostic Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 228: Australia Historic Review for Yersinia Diagnostics by Diagnostic Test - Stool Culture Test, Imaging Tests, Serological Tests, Colonoscopy Test and Other Diagnostic Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 229: Australia 16-Year Perspective for Yersinia Diagnostics by Diagnostic Test - Percentage Breakdown of Value Sales for Stool Culture Test, Imaging Tests, Serological Tests, Colonoscopy Test and Other Diagnostic Tests for the Years 2014, 2025 & 2030
• INDIA
  • Yersinia Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 230: India Recent Past, Current & Future Analysis for Yersinia Diagnostics by Product - Yersinia Diagnostic Instruments and Yersinia Diagnostic Kits & Reagents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 231: India Historic Review for Yersinia Diagnostics by Product - Yersinia Diagnostic Instruments and Yersinia Diagnostic Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 232: India 16-Year Perspective for Yersinia Diagnostics by Product - Percentage Breakdown of Value Sales for Yersinia Diagnostic Instruments and Yersinia Diagnostic Kits & Reagents for the Years 2014, 2025 & 2030
  • TABLE 233: India Recent Past, Current & Future Analysis for Yersinia Diagnostics by Technology - Polymerase Chain Reaction Technology, Flow Cytometry Technology, Chromatography Technology, Other Technologies, Immunoassay Technology and DNA Probes Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 234: India Historic Review for Yersinia Diagnostics by Technology - Polymerase Chain Reaction Technology, Flow Cytometry Technology, Chromatography Technology, Other Technologies, Immunoassay Technology and DNA Probes Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 235: India 16-Year Perspective for Yersinia Diagnostics by Technology - Percentage Breakdown of Value Sales for Polymerase Chain Reaction Technology, Flow Cytometry Technology, Chromatography Technology, Other Technologies, Immunoassay Technology and DNA Probes Technology for the Years 2014, 2025 & 2030
  • TABLE 236: India Recent Past, Current & Future Analysis for Yersinia Diagnostics by End-Use - Hospitals End-Use, Public Health Laboratories End-Use, Commercial Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 237: India Historic Review for Yersinia Diagnostics by End-Use - Hospitals End-Use, Public Health Laboratories End-Use, Commercial Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 238: India 16-Year Perspective for Yersinia Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Public Health Laboratories End-Use, Commercial Laboratories End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • TABLE 239: India Recent Past, Current & Future Analysis for Yersinia Diagnostics by Diagnostic Test - Stool Culture Test, Imaging Tests, Serological Tests, Colonoscopy Test and Other Diagnostic Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 240: India Historic Review for Yersinia Diagnostics by Diagnostic Test - Stool Culture Test, Imaging Tests, Serological Tests, Colonoscopy Test and Other Diagnostic Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 241: India 16-Year Perspective for Yersinia Diagnostics by Diagnostic Test - Percentage Breakdown of Value Sales for Stool Culture Test, Imaging Tests, Serological Tests, Colonoscopy Test and Other Diagnostic Tests for the Years 2014, 2025 & 2030
• SOUTH KOREA
  • TABLE 242: South Korea Recent Past, Current & Future Analysis for Yersinia Diagnostics by Product - Yersinia Diagnostic Instruments and Yersinia Diagnostic Kits & Reagents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 243: South Korea Historic Review for Yersinia Diagnostics by Product - Yersinia Diagnostic Instruments and Yersinia Diagnostic Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 244: South Korea 16-Year Perspective for Yersinia Diagnostics by Product - Percentage Breakdown of Value Sales for Yersinia Diagnostic Instruments and Yersinia Diagnostic Kits & Reagents for the Years 2014, 2025 & 2030
  • TABLE 245: South Korea Recent Past, Current & Future Analysis for Yersinia Diagnostics by Technology - Polymerase Chain Reaction Technology, Flow Cytometry Technology, Chromatography Technology, Other Technologies, Immunoassay Technology and DNA Probes Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 246: South Korea Historic Review for Yersinia Diagnostics by Technology - Polymerase Chain Reaction Technology, Flow Cytometry Technology, Chromatography Technology, Other Technologies, Immunoassay Technology and DNA Probes Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 247: South Korea 16-Year Perspective for Yersinia Diagnostics by Technology - Percentage Breakdown of Value Sales for Polymerase Chain Reaction Technology, Flow Cytometry Technology, Chromatography Technology, Other Technologies, Immunoassay Technology and DNA Probes Technology for the Years 2014, 2025 & 2030
  • TABLE 248: South Korea Recent Past, Current & Future Analysis for Yersinia Diagnostics by End-Use - Hospitals End-Use, Public Health Laboratories End-Use, Commercial Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 249: South Korea Historic Review for Yersinia Diagnostics by End-Use - Hospitals End-Use, Public Health Laboratories End-Use, Commercial Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 250: South Korea 16-Year Perspective for Yersinia Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Public Health Laboratories End-Use, Commercial Laboratories End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • TABLE 251: South Korea Recent Past, Current & Future Analysis for Yersinia Diagnostics by Diagnostic Test - Stool Culture Test, Imaging Tests, Serological Tests, Colonoscopy Test and Other Diagnostic Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 252: South Korea Historic Review for Yersinia Diagnostics by Diagnostic Test - Stool Culture Test, Imaging Tests, Serological Tests, Colonoscopy Test and Other Diagnostic Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 253: South Korea 16-Year Perspective for Yersinia Diagnostics by Diagnostic Test - Percentage Breakdown of Value Sales for Stool Culture Test, Imaging Tests, Serological Tests, Colonoscopy Test and Other Diagnostic Tests for the Years 2014, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 254: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Yersinia Diagnostics by Product - Yersinia Diagnostic Instruments and Yersinia Diagnostic Kits & Reagents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 255: Rest of Asia-Pacific Historic Review for Yersinia Diagnostics by Product - Yersinia Diagnostic Instruments and Yersinia Diagnostic Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 256: Rest of Asia-Pacific 16-Year Perspective for Yersinia Diagnostics by Product - Percentage Breakdown of Value Sales for Yersinia Diagnostic Instruments and Yersinia Diagnostic Kits & Reagents for the Years 2014, 2025 & 2030
  • TABLE 257: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Yersinia Diagnostics by Technology - Polymerase Chain Reaction Technology, Flow Cytometry Technology, Chromatography Technology, Other Technologies, Immunoassay Technology and DNA Probes Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 258: Rest of Asia-Pacific Historic Review for Yersinia Diagnostics by Technology - Polymerase Chain Reaction Technology, Flow Cytometry Technology, Chromatography Technology, Other Technologies, Immunoassay Technology and DNA Probes Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 259: Rest of Asia-Pacific 16-Year Perspective for Yersinia Diagnostics by Technology - Percentage Breakdown of Value Sales for Polymerase Chain Reaction Technology, Flow Cytometry Technology, Chromatography Technology, Other Technologies, Immunoassay Technology and DNA Probes Technology for the Years 2014, 2025 & 2030
  • TABLE 260: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Yersinia Diagnostics by End-Use - Hospitals End-Use, Public Health Laboratories End-Use, Commercial Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 261: Rest of Asia-Pacific Historic Review for Yersinia Diagnostics by End-Use - Hospitals End-Use, Public Health Laboratories End-Use, Commercial Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 262: Rest of Asia-Pacific 16-Year Perspective for Yersinia Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Public Health Laboratories End-Use, Commercial Laboratories End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • TABLE 263: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Yersinia Diagnostics by Diagnostic Test - Stool Culture Test, Imaging Tests, Serological Tests, Colonoscopy Test and Other Diagnostic Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 264: Rest of Asia-Pacific Historic Review for Yersinia Diagnostics by Diagnostic Test - Stool Culture Test, Imaging Tests, Serological Tests, Colonoscopy Test and Other Diagnostic Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 265: Rest of Asia-Pacific 16-Year Perspective for Yersinia Diagnostics by Diagnostic Test - Percentage Breakdown of Value Sales for Stool Culture Test, Imaging Tests, Serological Tests, Colonoscopy Test and Other Diagnostic Tests for the Years 2014, 2025 & 2030
• LATIN AMERICA
  • Yersinia Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 266: Latin America Recent Past, Current & Future Analysis for Yersinia Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 267: Latin America Historic Review for Yersinia Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 268: Latin America 16-Year Perspective for Yersinia Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
  • TABLE 269: Latin America Recent Past, Current & Future Analysis for Yersinia Diagnostics by Product - Yersinia Diagnostic Instruments and Yersinia Diagnostic Kits & Reagents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 270: Latin America Historic Review for Yersinia Diagnostics by Product - Yersinia Diagnostic Instruments and Yersinia Diagnostic Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 271: Latin America 16-Year Perspective for Yersinia Diagnostics by Product - Percentage Breakdown of Value Sales for Yersinia Diagnostic Instruments and Yersinia Diagnostic Kits & Reagents for the Years 2014, 2025 & 2030
  • TABLE 272: Latin America Recent Past, Current & Future Analysis for Yersinia Diagnostics by Technology - Polymerase Chain Reaction Technology, Flow Cytometry Technology, Chromatography Technology, Other Technologies, Immunoassay Technology and DNA Probes Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 273: Latin America Historic Review for Yersinia Diagnostics by Technology - Polymerase Chain Reaction Technology, Flow Cytometry Technology, Chromatography Technology, Other Technologies, Immunoassay Technology and DNA Probes Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 274: Latin America 16-Year Perspective for Yersinia Diagnostics by Technology - Percentage Breakdown of Value Sales for Polymerase Chain Reaction Technology, Flow Cytometry Technology, Chromatography Technology, Other Technologies, Immunoassay Technology and DNA Probes Technology for the Years 2014, 2025 & 2030
  • TABLE 275: Latin America Recent Past, Current & Future Analysis for Yersinia Diagnostics by End-Use - Hospitals End-Use, Public Health Laboratories End-Use, Commercial Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 276: Latin America Historic Review for Yersinia Diagnostics by End-Use - Hospitals End-Use, Public Health Laboratories End-Use, Commercial Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 277: Latin America 16-Year Perspective for Yersinia Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Public Health Laboratories End-Use, Commercial Laboratories End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • TABLE 278: Latin America Recent Past, Current & Future Analysis for Yersinia Diagnostics by Diagnostic Test - Stool Culture Test, Imaging Tests, Serological Tests, Colonoscopy Test and Other Diagnostic Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 279: Latin America Historic Review for Yersinia Diagnostics by Diagnostic Test - Stool Culture Test, Imaging Tests, Serological Tests, Colonoscopy Test and Other Diagnostic Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 280: Latin America 16-Year Perspective for Yersinia Diagnostics by Diagnostic Test - Percentage Breakdown of Value Sales for Stool Culture Test, Imaging Tests, Serological Tests, Colonoscopy Test and Other Diagnostic Tests for the Years 2014, 2025 & 2030
• ARGENTINA
  • TABLE 281: Argentina Recent Past, Current & Future Analysis for Yersinia Diagnostics by Product - Yersinia Diagnostic Instruments and Yersinia Diagnostic Kits & Reagents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 282: Argentina Historic Review for Yersinia Diagnostics by Product - Yersinia Diagnostic Instruments and Yersinia Diagnostic Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 283: Argentina 16-Year Perspective for Yersinia Diagnostics by Product - Percentage Breakdown of Value Sales for Yersinia Diagnostic Instruments and Yersinia Diagnostic Kits & Reagents for the Years 2014, 2025 & 2030
  • TABLE 284: Argentina Recent Past, Current & Future Analysis for Yersinia Diagnostics by Technology - Polymerase Chain Reaction Technology, Flow Cytometry Technology, Chromatography Technology, Other Technologies, Immunoassay Technology and DNA Probes Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 285: Argentina Historic Review for Yersinia Diagnostics by Technology - Polymerase Chain Reaction Technology, Flow Cytometry Technology, Chromatography Technology, Other Technologies, Immunoassay Technology and DNA Probes Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 286: Argentina 16-Year Perspective for Yersinia Diagnostics by Technology - Percentage Breakdown of Value Sales for Polymerase Chain Reaction Technology, Flow Cytometry Technology, Chromatography Technology, Other Technologies, Immunoassay Technology and DNA Probes Technology for the Years 2014, 2025 & 2030
  • TABLE 287: Argentina Recent Past, Current & Future Analysis for Yersinia Diagnostics by End-Use - Hospitals End-Use, Public Health Laboratories End-Use, Commercial Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 288: Argentina Historic Review for Yersinia Diagnostics by End-Use - Hospitals End-Use, Public Health Laboratories End-Use, Commercial Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 289: Argentina 16-Year Perspective for Yersinia Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Public Health Laboratories End-Use, Commercial Laboratories End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • TABLE 290: Argentina Recent Past, Current & Future Analysis for Yersinia Diagnostics by Diagnostic Test - Stool Culture Test, Imaging Tests, Serological Tests, Colonoscopy Test and Other Diagnostic Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 291: Argentina Historic Review for Yersinia Diagnostics by Diagnostic Test - Stool Culture Test, Imaging Tests, Serological Tests, Colonoscopy Test and Other Diagnostic Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 292: Argentina 16-Year Perspective for Yersinia Diagnostics by Diagnostic Test - Percentage Breakdown of Value Sales for Stool Culture Test, Imaging Tests, Serological Tests, Colonoscopy Test and Other Diagnostic Tests for the Years 2014, 2025 & 2030
• BRAZIL
  • TABLE 293: Brazil Recent Past, Current & Future Analysis for Yersinia Diagnostics by Product - Yersinia Diagnostic Instruments and Yersinia Diagnostic Kits & Reagents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 294: Brazil Historic Review for Yersinia Diagnostics by Product - Yersinia Diagnostic Instruments and Yersinia Diagnostic Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 295: Brazil 16-Year Perspective for Yersinia Diagnostics by Product - Percentage Breakdown of Value Sales for Yersinia Diagnostic Instruments and Yersinia Diagnostic Kits & Reagents for the Years 2014, 2025 & 2030
  • TABLE 296: Brazil Recent Past, Current & Future Analysis for Yersinia Diagnostics by Technology - Polymerase Chain Reaction Technology, Flow Cytometry Technology, Chromatography Technology, Other Technologies, Immunoassay Technology and DNA Probes Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 297: Brazil Historic Review for Yersinia Diagnostics by Technology - Polymerase Chain Reaction Technology, Flow Cytometry Technology, Chromatography Technology, Other Technologies, Immunoassay Technology and DNA Probes Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 298: Brazil 16-Year Perspective for Yersinia Diagnostics by Technology - Percentage Breakdown of Value Sales for Polymerase Chain Reaction Technology, Flow Cytometry Technology, Chromatography Technology, Other Technologies, Immunoassay Technology and DNA Probes Technology for the Years 2014, 2025 & 2030
  • TABLE 299: Brazil Recent Past, Current & Future Analysis for Yersinia Diagnostics by End-Use - Hospitals End-Use, Public Health Laboratories End-Use, Commercial Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 300: Brazil Historic Review for Yersinia Diagnostics by End-Use - Hospitals End-Use, Public Health Laboratories End-Use, Commercial Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 301: Brazil 16-Year Perspective for Yersinia Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Public Health Laboratories End-Use, Commercial Laboratories End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • TABLE 302: Brazil Recent Past, Current & Future Analysis for Yersinia Diagnostics by Diagnostic Test - Stool Culture Test, Imaging Tests, Serological Tests, Colonoscopy Test and Other Diagnostic Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 303: Brazil Historic Review for Yersinia Diagnostics by Diagnostic Test - Stool Culture Test, Imaging Tests, Serological Tests, Colonoscopy Test and Other Diagnostic Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 304: Brazil 16-Year Perspective for Yersinia Diagnostics by Diagnostic Test - Percentage Breakdown of Value Sales for Stool Culture Test, Imaging Tests, Serological Tests, Colonoscopy Test and Other Diagnostic Tests for the Years 2014, 2025 & 2030
• MEXICO
  • TABLE 305: Mexico Recent Past, Current & Future Analysis for Yersinia Diagnostics by Product - Yersinia Diagnostic Instruments and Yersinia Diagnostic Kits & Reagents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 306: Mexico Historic Review for Yersinia Diagnostics by Product - Yersinia Diagnostic Instruments and Yersinia Diagnostic Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 307: Mexico 16-Year Perspective for Yersinia Diagnostics by Product - Percentage Breakdown of Value Sales for Yersinia Diagnostic Instruments and Yersinia Diagnostic Kits & Reagents for the Years 2014, 2025 & 2030
  • TABLE 308: Mexico Recent Past, Current & Future Analysis for Yersinia Diagnostics by Technology - Polymerase Chain Reaction Technology, Flow Cytometry Technology, Chromatography Technology, Other Technologies, Immunoassay Technology and DNA Probes Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 309: Mexico Historic Review for Yersinia Diagnostics by Technology - Polymerase Chain Reaction Technology, Flow Cytometry Technology, Chromatography Technology, Other Technologies, Immunoassay Technology and DNA Probes Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 310: Mexico 16-Year Perspective for Yersinia Diagnostics by Technology - Percentage Breakdown of Value Sales for Polymerase Chain Reaction Technology, Flow Cytometry Technology, Chromatography Technology, Other Technologies, Immunoassay Technology and DNA Probes Technology for the Years 2014, 2025 & 2030
  • TABLE 311: Mexico Recent Past, Current & Future Analysis for Yersinia Diagnostics by End-Use - Hospitals End-Use, Public Health Laboratories End-Use, Commercial Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 312: Mexico Historic Review for Yersinia Diagnostics by End-Use - Hospitals End-Use, Public Health Laboratories End-Use, Commercial Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 313: Mexico 16-Year Perspective for Yersinia Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Public Health Laboratories End-Use, Commercial Laboratories End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • TABLE 314: Mexico Recent Past, Current & Future Analysis for Yersinia Diagnostics by Diagnostic Test - Stool Culture Test, Imaging Tests, Serological Tests, Colonoscopy Test and Other Diagnostic Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 315: Mexico Historic Review for Yersinia Diagnostics by Diagnostic Test - Stool Culture Test, Imaging Tests, Serological Tests, Colonoscopy Test and Other Diagnostic Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 316: Mexico 16-Year Perspective for Yersinia Diagnostics by Diagnostic Test - Percentage Breakdown of Value Sales for Stool Culture Test, Imaging Tests, Serological Tests, Colonoscopy Test and Other Diagnostic Tests for the Years 2014, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 317: Rest of Latin America Recent Past, Current & Future Analysis for Yersinia Diagnostics by Product - Yersinia Diagnostic Instruments and Yersinia Diagnostic Kits & Reagents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 318: Rest of Latin America Historic Review for Yersinia Diagnostics by Product - Yersinia Diagnostic Instruments and Yersinia Diagnostic Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 319: Rest of Latin America 16-Year Perspective for Yersinia Diagnostics by Product - Percentage Breakdown of Value Sales for Yersinia Diagnostic Instruments and Yersinia Diagnostic Kits & Reagents for the Years 2014, 2025 & 2030
  • TABLE 320: Rest of Latin America Recent Past, Current & Future Analysis for Yersinia Diagnostics by Technology - Polymerase Chain Reaction Technology, Flow Cytometry Technology, Chromatography Technology, Other Technologies, Immunoassay Technology and DNA Probes Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 321: Rest of Latin America Historic Review for Yersinia Diagnostics by Technology - Polymerase Chain Reaction Technology, Flow Cytometry Technology, Chromatography Technology, Other Technologies, Immunoassay Technology and DNA Probes Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 322: Rest of Latin America 16-Year Perspective for Yersinia Diagnostics by Technology - Percentage Breakdown of Value Sales for Polymerase Chain Reaction Technology, Flow Cytometry Technology, Chromatography Technology, Other Technologies, Immunoassay Technology and DNA Probes Technology for the Years 2014, 2025 & 2030
  • TABLE 323: Rest of Latin America Recent Past, Current & Future Analysis for Yersinia Diagnostics by End-Use - Hospitals End-Use, Public Health Laboratories End-Use, Commercial Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 324: Rest of Latin America Historic Review for Yersinia Diagnostics by End-Use - Hospitals End-Use, Public Health Laboratories End-Use, Commercial Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 325: Rest of Latin America 16-Year Perspective for Yersinia Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Public Health Laboratories End-Use, Commercial Laboratories End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • TABLE 326: Rest of Latin America Recent Past, Current & Future Analysis for Yersinia Diagnostics by Diagnostic Test - Stool Culture Test, Imaging Tests, Serological Tests, Colonoscopy Test and Other Diagnostic Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 327: Rest of Latin America Historic Review for Yersinia Diagnostics by Diagnostic Test - Stool Culture Test, Imaging Tests, Serological Tests, Colonoscopy Test and Other Diagnostic Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 328: Rest of Latin America 16-Year Perspective for Yersinia Diagnostics by Diagnostic Test - Percentage Breakdown of Value Sales for Stool Culture Test, Imaging Tests, Serological Tests, Colonoscopy Test and Other Diagnostic Tests for the Years 2014, 2025 & 2030
• MIDDLE EAST
  • Yersinia Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 329: Middle East Recent Past, Current & Future Analysis for Yersinia Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 330: Middle East Historic Review for Yersinia Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 331: Middle East 16-Year Perspective for Yersinia Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
  • TABLE 332: Middle East Recent Past, Current & Future Analysis for Yersinia Diagnostics by Product - Yersinia Diagnostic Instruments and Yersinia Diagnostic Kits & Reagents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 333: Middle East Historic Review for Yersinia Diagnostics by Product - Yersinia Diagnostic Instruments and Yersinia Diagnostic Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 334: Middle East 16-Year Perspective for Yersinia Diagnostics by Product - Percentage Breakdown of Value Sales for Yersinia Diagnostic Instruments and Yersinia Diagnostic Kits & Reagents for the Years 2014, 2025 & 2030
  • TABLE 335: Middle East Recent Past, Current & Future Analysis for Yersinia Diagnostics by Technology - Polymerase Chain Reaction Technology, Flow Cytometry Technology, Chromatography Technology, Other Technologies, Immunoassay Technology and DNA Probes Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 336: Middle East Historic Review for Yersinia Diagnostics by Technology - Polymerase Chain Reaction Technology, Flow Cytometry Technology, Chromatography Technology, Other Technologies, Immunoassay Technology and DNA Probes Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 337: Middle East 16-Year Perspective for Yersinia Diagnostics by Technology - Percentage Breakdown of Value Sales for Polymerase Chain Reaction Technology, Flow Cytometry Technology, Chromatography Technology, Other Technologies, Immunoassay Technology and DNA Probes Technology for the Years 2014, 2025 & 2030
  • TABLE 338: Middle East Recent Past, Current & Future Analysis for Yersinia Diagnostics by End-Use - Hospitals End-Use, Public Health Laboratories End-Use, Commercial Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 339: Middle East Historic Review for Yersinia Diagnostics by End-Use - Hospitals End-Use, Public Health Laboratories End-Use, Commercial Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 340: Middle East 16-Year Perspective for Yersinia Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Public Health Laboratories End-Use, Commercial Laboratories End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • TABLE 341: Middle East Recent Past, Current & Future Analysis for Yersinia Diagnostics by Diagnostic Test - Stool Culture Test, Imaging Tests, Serological Tests, Colonoscopy Test and Other Diagnostic Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 342: Middle East Historic Review for Yersinia Diagnostics by Diagnostic Test - Stool Culture Test, Imaging Tests, Serological Tests, Colonoscopy Test and Other Diagnostic Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 343: Middle East 16-Year Perspective for Yersinia Diagnostics by Diagnostic Test - Percentage Breakdown of Value Sales for Stool Culture Test, Imaging Tests, Serological Tests, Colonoscopy Test and Other Diagnostic Tests for the Years 2014, 2025 & 2030
• IRAN
  • TABLE 344: Iran Recent Past, Current & Future Analysis for Yersinia Diagnostics by Product - Yersinia Diagnostic Instruments and Yersinia Diagnostic Kits & Reagents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 345: Iran Historic Review for Yersinia Diagnostics by Product - Yersinia Diagnostic Instruments and Yersinia Diagnostic Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 346: Iran 16-Year Perspective for Yersinia Diagnostics by Product - Percentage Breakdown of Value Sales for Yersinia Diagnostic Instruments and Yersinia Diagnostic Kits & Reagents for the Years 2014, 2025 & 2030
  • TABLE 347: Iran Recent Past, Current & Future Analysis for Yersinia Diagnostics by Technology - Polymerase Chain Reaction Technology, Flow Cytometry Technology, Chromatography Technology, Other Technologies, Immunoassay Technology and DNA Probes Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 348: Iran Historic Review for Yersinia Diagnostics by Technology - Polymerase Chain Reaction Technology, Flow Cytometry Technology, Chromatography Technology, Other Technologies, Immunoassay Technology and DNA Probes Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 349: Iran 16-Year Perspective for Yersinia Diagnostics by Technology - Percentage Breakdown of Value Sales for Polymerase Chain Reaction Technology, Flow Cytometry Technology, Chromatography Technology, Other Technologies, Immunoassay Technology and DNA Probes Technology for the Years 2014, 2025 & 2030
  • TABLE 350: Iran Recent Past, Current & Future Analysis for Yersinia Diagnostics by End-Use - Hospitals End-Use, Public Health Laboratories End-Use, Commercial Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 351: Iran Historic Review for Yersinia Diagnostics by End-Use - Hospitals End-Use, Public Health Laboratories End-Use, Commercial Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 352: Iran 16-Year Perspective for Yersinia Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Public Health Laboratories End-Use, Commercial Laboratories End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • TABLE 353: Iran Recent Past, Current & Future Analysis for Yersinia Diagnostics by Diagnostic Test - Stool Culture Test, Imaging Tests, Serological Tests, Colonoscopy Test and Other Diagnostic Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 354: Iran Historic Review for Yersinia Diagnostics by Diagnostic Test - Stool Culture Test, Imaging Tests, Serological Tests, Colonoscopy Test and Other Diagnostic Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 355: Iran 16-Year Perspective for Yersinia Diagnostics by Diagnostic Test - Percentage Breakdown of Value Sales for Stool Culture Test, Imaging Tests, Serological Tests, Colonoscopy Test and Other Diagnostic Tests for the Years 2014, 2025 & 2030
• ISRAEL
  • TABLE 356: Israel Recent Past, Current & Future Analysis for Yersinia Diagnostics by Product - Yersinia Diagnostic Instruments and Yersinia Diagnostic Kits & Reagents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 357: Israel Historic Review for Yersinia Diagnostics by Product - Yersinia Diagnostic Instruments and Yersinia Diagnostic Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 358: Israel 16-Year Perspective for Yersinia Diagnostics by Product - Percentage Breakdown of Value Sales for Yersinia Diagnostic Instruments and Yersinia Diagnostic Kits & Reagents for the Years 2014, 2025 & 2030
  • TABLE 359: Israel Recent Past, Current & Future Analysis for Yersinia Diagnostics by Technology - Polymerase Chain Reaction Technology, Flow Cytometry Technology, Chromatography Technology, Other Technologies, Immunoassay Technology and DNA Probes Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 360: Israel Historic Review for Yersinia Diagnostics by Technology - Polymerase Chain Reaction Technology, Flow Cytometry Technology, Chromatography Technology, Other Technologies, Immunoassay Technology and DNA Probes Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 361: Israel 16-Year Perspective for Yersinia Diagnostics by Technology - Percentage Breakdown of Value Sales for Polymerase Chain Reaction Technology, Flow Cytometry Technology, Chromatography Technology, Other Technologies, Immunoassay Technology and DNA Probes Technology for the Years 2014, 2025 & 2030
  • TABLE 362: Israel Recent Past, Current & Future Analysis for Yersinia Diagnostics by End-Use - Hospitals End-Use, Public Health Laboratories End-Use, Commercial Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 363: Israel Historic Review for Yersinia Diagnostics by End-Use - Hospitals End-Use, Public Health Laboratories End-Use, Commercial Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 364: Israel 16-Year Perspective for Yersinia Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Public Health Laboratories End-Use, Commercial Laboratories End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • TABLE 365: Israel Recent Past, Current & Future Analysis for Yersinia Diagnostics by Diagnostic Test - Stool Culture Test, Imaging Tests, Serological Tests, Colonoscopy Test and Other Diagnostic Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 366: Israel Historic Review for Yersinia Diagnostics by Diagnostic Test - Stool Culture Test, Imaging Tests, Serological Tests, Colonoscopy Test and Other Diagnostic Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 367: Israel 16-Year Perspective for Yersinia Diagnostics by Diagnostic Test - Percentage Breakdown of Value Sales for Stool Culture Test, Imaging Tests, Serological Tests, Colonoscopy Test and Other Diagnostic Tests for the Years 2014, 2025 & 2030
• SAUDI ARABIA
  • TABLE 368: Saudi Arabia Recent Past, Current & Future Analysis for Yersinia Diagnostics by Product - Yersinia Diagnostic Instruments and Yersinia Diagnostic Kits & Reagents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 369: Saudi Arabia Historic Review for Yersinia Diagnostics by Product - Yersinia Diagnostic Instruments and Yersinia Diagnostic Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 370: Saudi Arabia 16-Year Perspective for Yersinia Diagnostics by Product - Percentage Breakdown of Value Sales for Yersinia Diagnostic Instruments and Yersinia Diagnostic Kits & Reagents for the Years 2014, 2025 & 2030
  • TABLE 371: Saudi Arabia Recent Past, Current & Future Analysis for Yersinia Diagnostics by Technology - Polymerase Chain Reaction Technology, Flow Cytometry Technology, Chromatography Technology, Other Technologies, Immunoassay Technology and DNA Probes Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 372: Saudi Arabia Historic Review for Yersinia Diagnostics by Technology - Polymerase Chain Reaction Technology, Flow Cytometry Technology, Chromatography Technology, Other Technologies, Immunoassay Technology and DNA Probes Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 373: Saudi Arabia 16-Year Perspective for Yersinia Diagnostics by Technology - Percentage Breakdown of Value Sales for Polymerase Chain Reaction Technology, Flow Cytometry Technology, Chromatography Technology, Other Technologies, Immunoassay Technology and DNA Probes Technology for the Years 2014, 2025 & 2030
  • TABLE 374: Saudi Arabia Recent Past, Current & Future Analysis for Yersinia Diagnostics by End-Use - Hospitals End-Use, Public Health Laboratories End-Use, Commercial Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 375: Saudi Arabia Historic Review for Yersinia Diagnostics by End-Use - Hospitals End-Use, Public Health Laboratories End-Use, Commercial Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 376: Saudi Arabia 16-Year Perspective for Yersinia Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Public Health Laboratories End-Use, Commercial Laboratories End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • TABLE 377: Saudi Arabia Recent Past, Current & Future Analysis for Yersinia Diagnostics by Diagnostic Test - Stool Culture Test, Imaging Tests, Serological Tests, Colonoscopy Test and Other Diagnostic Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 378: Saudi Arabia Historic Review for Yersinia Diagnostics by Diagnostic Test - Stool Culture Test, Imaging Tests, Serological Tests, Colonoscopy Test and Other Diagnostic Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 379: Saudi Arabia 16-Year Perspective for Yersinia Diagnostics by Diagnostic Test - Percentage Breakdown of Value Sales for Stool Culture Test, Imaging Tests, Serological Tests, Colonoscopy Test and Other Diagnostic Tests for the Years 2014, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 380: UAE Recent Past, Current & Future Analysis for Yersinia Diagnostics by Product - Yersinia Diagnostic Instruments and Yersinia Diagnostic Kits & Reagents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 381: UAE Historic Review for Yersinia Diagnostics by Product - Yersinia Diagnostic Instruments and Yersinia Diagnostic Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 382: UAE 16-Year Perspective for Yersinia Diagnostics by Product - Percentage Breakdown of Value Sales for Yersinia Diagnostic Instruments and Yersinia Diagnostic Kits & Reagents for the Years 2014, 2025 & 2030
  • TABLE 383: UAE Recent Past, Current & Future Analysis for Yersinia Diagnostics by Technology - Polymerase Chain Reaction Technology, Flow Cytometry Technology, Chromatography Technology, Other Technologies, Immunoassay Technology and DNA Probes Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 384: UAE Historic Review for Yersinia Diagnostics by Technology - Polymerase Chain Reaction Technology, Flow Cytometry Technology, Chromatography Technology, Other Technologies, Immunoassay Technology and DNA Probes Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 385: UAE 16-Year Perspective for Yersinia Diagnostics by Technology - Percentage Breakdown of Value Sales for Polymerase Chain Reaction Technology, Flow Cytometry Technology, Chromatography Technology, Other Technologies, Immunoassay Technology and DNA Probes Technology for the Years 2014, 2025 & 2030
  • TABLE 386: UAE Recent Past, Current & Future Analysis for Yersinia Diagnostics by End-Use - Hospitals End-Use, Public Health Laboratories End-Use, Commercial Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 387: UAE Historic Review for Yersinia Diagnostics by End-Use - Hospitals End-Use, Public Health Laboratories End-Use, Commercial Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 388: UAE 16-Year Perspective for Yersinia Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Public Health Laboratories End-Use, Commercial Laboratories End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • TABLE 389: UAE Recent Past, Current & Future Analysis for Yersinia Diagnostics by Diagnostic Test - Stool Culture Test, Imaging Tests, Serological Tests, Colonoscopy Test and Other Diagnostic Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 390: UAE Historic Review for Yersinia Diagnostics by Diagnostic Test - Stool Culture Test, Imaging Tests, Serological Tests, Colonoscopy Test and Other Diagnostic Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 391: UAE 16-Year Perspective for Yersinia Diagnostics by Diagnostic Test - Percentage Breakdown of Value Sales for Stool Culture Test, Imaging Tests, Serological Tests, Colonoscopy Test and Other Diagnostic Tests for the Years 2014, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 392: Rest of Middle East Recent Past, Current & Future Analysis for Yersinia Diagnostics by Product - Yersinia Diagnostic Instruments and Yersinia Diagnostic Kits & Reagents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 393: Rest of Middle East Historic Review for Yersinia Diagnostics by Product - Yersinia Diagnostic Instruments and Yersinia Diagnostic Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 394: Rest of Middle East 16-Year Perspective for Yersinia Diagnostics by Product - Percentage Breakdown of Value Sales for Yersinia Diagnostic Instruments and Yersinia Diagnostic Kits & Reagents for the Years 2014, 2025 & 2030
  • TABLE 395: Rest of Middle East Recent Past, Current & Future Analysis for Yersinia Diagnostics by Technology - Polymerase Chain Reaction Technology, Flow Cytometry Technology, Chromatography Technology, Other Technologies, Immunoassay Technology and DNA Probes Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 396: Rest of Middle East Historic Review for Yersinia Diagnostics by Technology - Polymerase Chain Reaction Technology, Flow Cytometry Technology, Chromatography Technology, Other Technologies, Immunoassay Technology and DNA Probes Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 397: Rest of Middle East 16-Year Perspective for Yersinia Diagnostics by Technology - Percentage Breakdown of Value Sales for Polymerase Chain Reaction Technology, Flow Cytometry Technology, Chromatography Technology, Other Technologies, Immunoassay Technology and DNA Probes Technology for the Years 2014, 2025 & 2030
  • TABLE 398: Rest of Middle East Recent Past, Current & Future Analysis for Yersinia Diagnostics by End-Use - Hospitals End-Use, Public Health Laboratories End-Use, Commercial Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 399: Rest of Middle East Historic Review for Yersinia Diagnostics by End-Use - Hospitals End-Use, Public Health Laboratories End-Use, Commercial Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 400: Rest of Middle East 16-Year Perspective for Yersinia Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Public Health Laboratories End-Use, Commercial Laboratories End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • TABLE 401: Rest of Middle East Recent Past, Current & Future Analysis for Yersinia Diagnostics by Diagnostic Test - Stool Culture Test, Imaging Tests, Serological Tests, Colonoscopy Test and Other Diagnostic Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 402: Rest of Middle East Historic Review for Yersinia Diagnostics by Diagnostic Test - Stool Culture Test, Imaging Tests, Serological Tests, Colonoscopy Test and Other Diagnostic Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 403: Rest of Middle East 16-Year Perspective for Yersinia Diagnostics by Diagnostic Test - Percentage Breakdown of Value Sales for Stool Culture Test, Imaging Tests, Serological Tests, Colonoscopy Test and Other Diagnostic Tests for the Years 2014, 2025 & 2030
• AFRICA
  • Yersinia Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 404: Africa Recent Past, Current & Future Analysis for Yersinia Diagnostics by Product - Yersinia Diagnostic Instruments and Yersinia Diagnostic Kits & Reagents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 405: Africa Historic Review for Yersinia Diagnostics by Product - Yersinia Diagnostic Instruments and Yersinia Diagnostic Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 406: Africa 16-Year Perspective for Yersinia Diagnostics by Product - Percentage Breakdown of Value Sales for Yersinia Diagnostic Instruments and Yersinia Diagnostic Kits & Reagents for the Years 2014, 2025 & 2030
  • TABLE 407: Africa Recent Past, Current & Future Analysis for Yersinia Diagnostics by Technology - Polymerase Chain Reaction Technology, Flow Cytometry Technology, Chromatography Technology, Other Technologies, Immunoassay Technology and DNA Probes Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 408: Africa Historic Review for Yersinia Diagnostics by Technology - Polymerase Chain Reaction Technology, Flow Cytometry Technology, Chromatography Technology, Other Technologies, Immunoassay Technology and DNA Probes Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 409: Africa 16-Year Perspective for Yersinia Diagnostics by Technology - Percentage Breakdown of Value Sales for Polymerase Chain Reaction Technology, Flow Cytometry Technology, Chromatography Technology, Other Technologies, Immunoassay Technology and DNA Probes Technology for the Years 2014, 2025 & 2030
  • TABLE 410: Africa Recent Past, Current & Future Analysis for Yersinia Diagnostics by End-Use - Hospitals End-Use, Public Health Laboratories End-Use, Commercial Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 411: Africa Historic Review for Yersinia Diagnostics by End-Use - Hospitals End-Use, Public Health Laboratories End-Use, Commercial Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 412: Africa 16-Year Perspective for Yersinia Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Public Health Laboratories End-Use, Commercial Laboratories End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • TABLE 413: Africa Recent Past, Current & Future Analysis for Yersinia Diagnostics by Diagnostic Test - Stool Culture Test, Imaging Tests, Serological Tests, Colonoscopy Test and Other Diagnostic Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 414: Africa Historic Review for Yersinia Diagnostics by Diagnostic Test - Stool Culture Test, Imaging Tests, Serological Tests, Colonoscopy Test and Other Diagnostic Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 415: Africa 16-Year Perspective for Yersinia Diagnostics by Diagnostic Test - Percentage Breakdown of Value Sales for Stool Culture Test, Imaging Tests, Serological Tests, Colonoscopy Test and Other Diagnostic Tests for the Years 2014, 2025 & 2030

IV. COMPETITION